NIH awarded OMRF $3 million to study anti-aging abilities of a diabetic drug
Oklahoma Medical Research Foundation (OMRF) - 13-Jul-2022Investigation of ability of metformin, a diabetic drug to slow the process of aging
Join the club for FREE to access the whole archive and other member benefits.
Biomedical research institute developing effective treatments for different human diseases.
OMRF was founded as a non-profit organization in 1946 with the mission of conducting basic biomedical research to help people live longer, healthier lives. Our scientists are dedicated to understanding and curing human disease and focus on such critical research areas as lupus, multiple sclerosis, heart disease, cancer and Alzheimer’s disease.
From OMRF’s inception, our scientists have focused on making laboratory breakthroughs that have a tangible impact on human health. Researchers at OMRF made discoveries that proved crucial to the creation of the protease inhibition cocktails that have added decades to the lives of patients suffering from HIV/AIDS. OMRF discoveries have given birth to a drug to treat children suffering from a life-threatening deficiency of protein C. Work in our labs also led to the creation of Soliris, the first and only treatment for a rare blood disorder known as PNH. A drug with OMRF roots became the first drug licensed under the European Union’s centralized procedure. And our researchers have created diagnostic and disease management tests for lupus and rheumatoid arthritis that are used in hospitals and clinics around the world.
Visit website: https://omrf.org/
omrf---the-oklahoma-medical-research-foundation
Details last updated 12-Dec-2019
Investigation of ability of metformin, a diabetic drug to slow the process of aging
Interesting - metformin plus exercise did not have an additive effect